These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21449977)

  • 21. Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans.
    Nanjee MN; Cooke CJ; Garvin R; Semeria F; Lewis G; Olszewski WL; Miller NE
    J Lipid Res; 2001 Oct; 42(10):1586-93. PubMed ID: 11590214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerobic exercise improves reverse cholesterol transport in cholesteryl ester transfer protein transgenic mice.
    Rocco DD; Okuda LS; Pinto RS; Ferreira FD; Kubo SK; Nakandakare ER; Quintão EC; Catanozi S; Passarelli M
    Lipids; 2011 Jul; 46(7):617-25. PubMed ID: 21479674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xanthohumol, a hop-derived prenylated flavonoid, promotes macrophage reverse cholesterol transport.
    Hirata H; Uto-Kondo H; Ogura M; Ayaori M; Shiotani K; Ota A; Tsuchiya Y; Ikewaki K
    J Nutr Biochem; 2017 Sep; 47():29-34. PubMed ID: 28501703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholesterol 7alpha-hydroxylase influences the expression of hepatic apoA-I in two inbred mouse strains displaying different susceptibilities to atherosclerosis and in hepatoma cells.
    Dueland S; France D; Wang SL; Trawick JD; Davis RA
    J Lipid Res; 1997 Jul; 38(7):1445-53. PubMed ID: 9254069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration.
    Forte TM; Oda MN; Knoff L; Frei B; Suh J; Harmony JA; Stuart WD; Rubin EM; Ng DS
    J Lipid Res; 1999 Jul; 40(7):1276-83. PubMed ID: 10393212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary fat elevates hepatic apoA-I production by increasing the fraction of apolipoprotein A-I mRNA in the translating pool.
    Azrolan N; Odaka H; Breslow JL; Fisher EA
    J Biol Chem; 1995 Aug; 270(34):19833-8. PubMed ID: 7649994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
    Srivastava RA; Srivastava N; Averna M
    Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis.
    Hennuyer N; Duplan I; Paquet C; Vanhoutte J; Woitrain E; Touche V; Colin S; Vallez E; Lestavel S; Lefebvre P; Staels B
    Atherosclerosis; 2016 Jun; 249():200-8. PubMed ID: 27108950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma.
    Annema W; Dikkers A; Freark de Boer J; Gautier T; Rensen PCN; Rader DJ; Tietge UJF
    J Lipid Res; 2012 May; 53(5):929-940. PubMed ID: 22383685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration.
    Chen X; Burton C; Song X; McNamara L; Langella A; Cianetti S; Chang CH; Wang J
    Int J Biol Sci; 2009 Jul; 5(5):489-99. PubMed ID: 19680471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.
    Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM
    Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary fats differentially modulate the expression of lecithin:cholesterol acyltransferase, apoprotein-A1 and scavenger receptor b1 in rats.
    Hatahet W; Cole L; Kudchodkar BJ; Fungwe TV
    J Nutr; 2003 Mar; 133(3):689-94. PubMed ID: 12612138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes.
    Fournier N; Atger V; Paul JP; de la Llera Moya M; Rothblat G; Moatti N
    Atherosclerosis; 1999 Dec; 147(2):227-35. PubMed ID: 10559507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux.
    Daum U; Langer C; Duverger N; Emmanuel F; Benoit P; Denèfle P; Chirazi A; Cullen P; Pritchard PH; Bruckert E; Assmann G; von Eckardstein A
    J Mol Med (Berl); 1999 Aug; 77(8):614-22. PubMed ID: 10543393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro.
    O K; Frohlich J
    J Lipid Res; 1995 Nov; 36(11):2344-54. PubMed ID: 8656072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
    Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ
    Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary nucleotides enhance plasma lecithin cholesterol acyl transferase activity and apolipoprotein A-IV concentration in preterm newborn infants.
    Sánchez-Pozo A; Ramírez M; Gil A; Maldonado J; van Biervliet JP; Rosseneu M
    Pediatr Res; 1995 Mar; 37(3):328-33. PubMed ID: 7784143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haptoglobin binds the antiatherogenic protein apolipoprotein E - impairment of apolipoprotein E stimulation of both lecithin:cholesterol acyltransferase activity and cholesterol uptake by hepatocytes.
    Cigliano L; Pugliese CR; Spagnuolo MS; Palumbo R; Abrescia P
    FEBS J; 2009 Nov; 276(21):6158-71. PubMed ID: 19758344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hepatic HDL-related mRNAs on plasma prebeta HDL in cholesterol-fed rabbits.
    Sugano M; Makino N; Yanaga T
    Artery; 1997; 22(4):182-205. PubMed ID: 9576025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance.
    Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2001 Feb; 42(2):241-8. PubMed ID: 11181754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.